25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

0013 (HUTCHMED China Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze HUTCHMED China Ltd together

I guess you are interested in HUTCHMED China Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – HUTCHMED China Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – HUTCHMED China Ltd’s Price Targets

I'm going to help you getting a better view of HUTCHMED China Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about HUTCHMED China Ltd

I send you an email if I find something interesting about HUTCHMED China Ltd.

1. Quick Overview

1.1. Quick analysis of HUTCHMED China Ltd (30 sec.)










1.2. What can you expect buying and holding a share of HUTCHMED China Ltd? (30 sec.)

How much money do you get?

How much money do you get?
HK$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
HK$7.00
Expected worth in 1 year
HK$8.48
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
HK$1.48
Return On Investment
6.3%

For what price can you sell your share?

Current Price per Share
HK$23.50
Expected price per share
HK$17.44 - HK$26.80
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of HUTCHMED China Ltd (5 min.)




Live pricePrice per Share (EOD)
HK$23.50
Intrinsic Value Per Share
HK$-6.81 - HK$24.01
Total Value Per Share
HK$0.20 - HK$31.02

2.2. Growth of HUTCHMED China Ltd (5 min.)




Is HUTCHMED China Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$771.7m$743.2m$28.4m3.7%

How much money is HUTCHMED China Ltd making?

Current yearPrevious yearGrowGrow %
Making money$37.7m$100.7m-$63m-167.1%
Net Profit Margin6.0%12.0%--

How much money comes from the company's main activities?

2.3. Financial Health of HUTCHMED China Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of HUTCHMED China Ltd?

Welcome investor! HUTCHMED China Ltd's management wants to use your money to grow the business. In return you get a share of HUTCHMED China Ltd.

First you should know what it really means to hold a share of HUTCHMED China Ltd. And how you can make/lose money.

Speculation

The Price per Share of HUTCHMED China Ltd is HK$23.50. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of HUTCHMED China Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in HUTCHMED China Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is HK$7.00. Based on the TTM, the Book Value Change Per Share is HK$0.37 per quarter. Based on the YOY, the Book Value Change Per Share is HK$0.86 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is HK$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of HUTCHMED China Ltd.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 HK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per ShareHK$% of Price per Share
Usd Eps0.040.2%0.040.2%0.120.5%-0.09-0.4%-0.13-0.5%-0.09-0.4%
Usd Book Value Change Per Share0.050.2%0.050.2%0.110.5%-0.10-0.4%0.110.5%0.080.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.050.2%0.050.2%0.110.5%-0.10-0.4%0.110.5%0.080.3%
Usd Price Per Share2.89-2.89-3.70-3.23-3.40-1.70-
Price to Earnings Ratio65.43-65.43-31.91-30.01-11.58-5.79-
Price-to-Total Gains Ratio60.65-60.65-33.55-29.21-24.91-24.91-
Price to Book Ratio3.20-3.20-4.33-3.89-3.54-1.77-
Price-to-Total Gains Ratio60.65-60.65-33.55-29.21-24.91-24.91-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.02915
Number of shares330
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.050.11
Usd Total Gains Per Share0.050.11
Gains per Quarter (330 shares)15.7135.43
Gains per Year (330 shares)62.84141.71
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1063530142132
201261160283274
301891790425416
402512420567558
503143050709700
603773680850842
704404310992984
80503494011341126
90566557012751268
100628620014171410

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%4.06.00.040.0%8.012.00.040.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%6.04.00.060.0%11.09.00.055.0%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%2.00.08.020.0%3.00.017.015.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%6.04.00.060.0%11.09.00.055.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of HUTCHMED China Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.3690.3690%0.855-57%-0.810+319%0.833-56%0.592-38%
Book Value Per Share--7.0037.0030%6.634+6%6.472+8%6.711+4%4.732+48%
Current Ratio--2.8322.8320%2.722+4%2.642+7%3.033-7%2.930-3%
Debt To Asset Ratio--0.3940.3940%0.419-6%0.398-1%0.344+15%0.342+15%
Debt To Equity Ratio--0.6610.6610%0.734-10%0.679-3%0.560+18%0.616+7%
Dividend Per Share----0%-0%-0%-0%0.013-100%
Enterprise Value--15252927169.40015252927169.4000%27660357357.600-45%21759945362.533-30%29753755318.250-49%29753755318.250-49%
Eps--0.3420.3420%0.899-62%-0.677+298%-0.988+389%-0.664+294%
Ev To Sales Ratio--3.1203.1200%4.255-27%4.713-34%8.398-63%8.398-63%
Free Cash Flow Per Share---0.158-0.1580%1.666-109%-0.421+166%-0.802+407%-0.554+250%
Free Cash Flow To Equity Per Share---0.158-0.1580%2.100-108%-0.526+233%0.853-119%0.591-127%
Gross Profit Margin--1.0001.0000%0.470+113%0.859+16%0.960+4%0.804+24%
Intrinsic Value_10Y_max--24.014----------
Intrinsic Value_10Y_min---6.808----------
Intrinsic Value_1Y_max--0.189----------
Intrinsic Value_1Y_min---0.779----------
Intrinsic Value_3Y_max--2.258----------
Intrinsic Value_3Y_min---2.271----------
Intrinsic Value_5Y_max--6.364----------
Intrinsic Value_5Y_min---3.675----------
Market Cap20089773248.000+5%19149400883.20019149400883.2000%24945935187.600-23%21537517100.933-11%22616894457.680-15%11308447228.840+69%
Net Profit Margin--0.0600.0600%0.120-50%-0.261+535%-0.455+860%-0.334+658%
Operating Margin----0%0.070-100%-0.2970%-0.5330%-0.4230%
Operating Ratio--1.6181.6180%0.978+65%1.517+7%1.667-3%1.496+8%
Pb Ratio3.356+5%3.1993.1990%4.326-26%3.893-18%3.538-10%1.769+81%
Pe Ratio68.648+5%65.43565.4350%31.912+105%30.005+118%11.582+465%5.791+1030%
Price Per Share23.500+5%22.40022.4000%28.700-22%25.033-11%26.360-15%13.180+70%
Price To Free Cash Flow Ratio-148.545-5%-141.591-141.5910%17.231-922%-44.342-69%-32.261-77%-16.130-89%
Price To Total Gains Ratio63.626+5%60.64860.6480%33.552+81%29.210+108%24.909+143%24.909+143%
Quick Ratio--2.2252.2250%3.985-44%3.056-27%3.805-42%3.815-42%
Return On Assets--0.0300.0300%0.079-62%-0.097+427%-0.145+589%-0.115+489%
Return On Equity--0.0500.0500%0.138-64%-0.161+425%-0.223+550%-0.171+444%
Total Gains Per Share--0.3690.3690%0.855-57%-0.810+319%0.833-56%0.604-39%
Usd Book Value--771718496.896771718496.8960%743257457.381+4%717244991.104+8%741985279.110+4%522612313.706+48%
Usd Book Value Change Per Share--0.0480.0480%0.110-57%-0.104+319%0.107-56%0.076-38%
Usd Book Value Per Share--0.9030.9030%0.855+6%0.834+8%0.865+4%0.610+48%
Usd Dividend Per Share----0%-0%-0%-0%0.002-100%
Usd Enterprise Value--1966102312.1361966102312.1360%3565420063.395-45%2804856957.231-30%3835259060.522-49%3835259060.522-49%
Usd Eps--0.0440.0440%0.116-62%-0.087+298%-0.127+389%-0.086+294%
Usd Free Cash Flow---17432961.603-17432961.6030%186613475.068-109%-45343097.135+160%-87720311.194+403%-60782706.160+249%
Usd Free Cash Flow Per Share---0.020-0.0200%0.215-109%-0.054+166%-0.103+407%-0.071+250%
Usd Free Cash Flow To Equity Per Share---0.020-0.0200%0.271-108%-0.068+233%0.110-119%0.076-127%
Usd Market Cap2589571771.667+5%2468357773.8442468357773.8440%3215531045.682-23%2776185954.310-11%2915317695.595-15%1457658847.797+69%
Usd Price Per Share3.029+5%2.8872.8870%3.699-22%3.227-11%3.398-15%1.699+70%
Usd Profit--37722425.34437722425.3440%100762438.077-63%-90527555.252+340%-138746017.905+468%-91992066.668+344%
Usd Revenue--630091181.174630091181.1740%837852970.294-25%631426281.8120%495656211.895+27%353258230.492+78%
Usd Total Gains Per Share--0.0480.0480%0.110-57%-0.104+319%0.107-56%0.078-39%
 EOD+5 -3MRQTTM+0 -0YOY+11 -263Y+26 -105Y+19 -1710Y+19 -19

3.3 Fundamental Score

Let's check the fundamental score of HUTCHMED China Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1568.648
Price to Book Ratio (EOD)Between0-13.356
Net Profit Margin (MRQ)Greater than00.060
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.225
Current Ratio (MRQ)Greater than12.832
Debt to Asset Ratio (MRQ)Less than10.394
Debt to Equity Ratio (MRQ)Less than10.661
Return on Equity (MRQ)Greater than0.150.050
Return on Assets (MRQ)Greater than0.050.030
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of HUTCHMED China Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.046
Ma 20Greater thanMa 5022.977
Ma 50Greater thanMa 10023.753
Ma 100Greater thanMa 20023.479
OpenGreater thanClose23.550
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About HUTCHMED China Ltd

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally. The company offers Fruquintinib, a selective and potent oral inhibitor of vascular endothelial growth factor receptors for treatment of colorectal cancer (CRC), breast cancer, gastric cancer (GC), microsatellite stable-CRC endometrial cancer (EMC), non-small cell lung cancer (NSCLC), renal cell carcinoma (RCC), endometrial cancer (EMC); and Savolitinib, a potent and selective inhibitor of mesenchymal-epithelial transition receptor to treat NSCLC, papillary RCC, and GC. It also develops Surufatinib to trea pancreatic neuroendocrine tumor (NET), non pancreatic NET, and pancreatic ductal adenocarcinoma; Sovleplenib, to treat immune thrombocytopenic purpura and warm autoimmune hemolytic anemia; and Tazemetostat, a treatment for epithelioid sarcoma and follicular lymphoma; Fanregratinib that treats intrahepatic cholangiocarcinoma; and Ranosidenib, a novel dual-inhibitor of dehydrogenase-1 and isocitrate dehydrogenase-2 enzymes to treat acute myeloid leukemia (AML). In addition, the company is developing HMPL-760, which is in phase I and II clinical trial to treat relapsed and/or refractory diffuse large B cell lymphoma, chronic lymphocytic leukemia, small lymphocytic lymphoma, and other B-NHL; HMPL-506 to treat Mixed-lineage leukemia-rearrange/rearrangement and nucleophosmin 1-mutantAML. It has collaboration agreements with AstraZeneca AB (publ), Lilly (Shanghai) Management Company Limited, Takeda, BeiGene Ltd., Inmagene Biopharmaceuticals Co. Ltd., Innovent Biologics Co., Inc., and Epizyme, Inc., and Epizyme, Inc. The company was formerly known as Hutchison China MediTech Limited and changed its name to HUTCHMED (China) Limited in May 2021. HUTCHMED (China) Limited was incorporated in 2000 and is headquartered in Hong Kong, Hong Kong.

Fundamental data was last updated by Penke on 2025-04-16 04:21:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit HUTCHMED China Ltd earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare HUTCHMED China Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 6.0% means that $0.06 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of HUTCHMED China Ltd:

  • The MRQ is 6.0%. The company is making a profit. +1
  • The TTM is 6.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ6.0%TTM6.0%0.0%
TTM6.0%YOY12.0%-6.0%
TTM6.0%5Y-45.5%+51.5%
5Y-45.5%10Y-33.4%-12.1%
4.3.1.2. Return on Assets

Shows how efficient HUTCHMED China Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare HUTCHMED China Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.0% Return on Assets means that HUTCHMED China Ltd generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of HUTCHMED China Ltd:

  • The MRQ is 3.0%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.0%TTM3.0%0.0%
TTM3.0%YOY7.9%-4.9%
TTM3.0%5Y-14.5%+17.5%
5Y-14.5%10Y-11.5%-3.0%
4.3.1.3. Return on Equity

Shows how efficient HUTCHMED China Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare HUTCHMED China Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • 5.0% Return on Equity means HUTCHMED China Ltd generated $0.05 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of HUTCHMED China Ltd:

  • The MRQ is 5.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 5.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ5.0%TTM5.0%0.0%
TTM5.0%YOY13.8%-8.8%
TTM5.0%5Y-22.3%+27.3%
5Y-22.3%10Y-17.1%-5.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of HUTCHMED China Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient HUTCHMED China Ltd is operating .

  • Measures how much profit HUTCHMED China Ltd makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare HUTCHMED China Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of HUTCHMED China Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY7.0%-7.0%
TTM-5Y-53.3%+53.3%
5Y-53.3%10Y-42.3%-11.0%
4.3.2.2. Operating Ratio

Measures how efficient HUTCHMED China Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.62 means that the operating costs are $1.62 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of HUTCHMED China Ltd:

  • The MRQ is 1.618. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.618. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.618TTM1.6180.000
TTM1.618YOY0.978+0.640
TTM1.6185Y1.667-0.049
5Y1.66710Y1.496+0.171
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of HUTCHMED China Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if HUTCHMED China Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 2.83 means the company has $2.83 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of HUTCHMED China Ltd:

  • The MRQ is 2.832. The company is able to pay all its short-term debts. +1
  • The TTM is 2.832. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.832TTM2.8320.000
TTM2.832YOY2.722+0.111
TTM2.8325Y3.033-0.201
5Y3.03310Y2.930+0.103
4.4.3.2. Quick Ratio

Measures if HUTCHMED China Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare HUTCHMED China Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 2.22 means the company can pay off $2.22 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of HUTCHMED China Ltd:

  • The MRQ is 2.225. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.225. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.225TTM2.2250.000
TTM2.225YOY3.985-1.760
TTM2.2255Y3.805-1.581
5Y3.80510Y3.815-0.010
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of HUTCHMED China Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of HUTCHMED China Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare HUTCHMED China Ltd to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.39 means that HUTCHMED China Ltd assets are financed with 39.4% credit (debt) and the remaining percentage (100% - 39.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of HUTCHMED China Ltd:

  • The MRQ is 0.394. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.394. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.394TTM0.3940.000
TTM0.394YOY0.419-0.025
TTM0.3945Y0.344+0.050
5Y0.34410Y0.342+0.002
4.5.4.2. Debt to Equity Ratio

Measures if HUTCHMED China Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare HUTCHMED China Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 66.1% means that company has $0.66 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of HUTCHMED China Ltd:

  • The MRQ is 0.661. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.661. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.661TTM0.6610.000
TTM0.661YOY0.734-0.073
TTM0.6615Y0.560+0.101
5Y0.56010Y0.616-0.056
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings HUTCHMED China Ltd generates.

  • Above 15 is considered overpriced but always compare HUTCHMED China Ltd to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 65.43 means the investor is paying $65.43 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of HUTCHMED China Ltd:

  • The EOD is 68.648. Based on the earnings, the company is expensive. -2
  • The MRQ is 65.435. Based on the earnings, the company is expensive. -2
  • The TTM is 65.435. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD68.648MRQ65.435+3.213
MRQ65.435TTM65.4350.000
TTM65.435YOY31.912+33.523
TTM65.4355Y11.582+53.852
5Y11.58210Y5.791+5.791
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of HUTCHMED China Ltd:

  • The EOD is -148.545. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -141.591. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -141.591. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-148.545MRQ-141.591-6.953
MRQ-141.591TTM-141.5910.000
TTM-141.591YOY17.231-158.822
TTM-141.5915Y-32.261-109.330
5Y-32.26110Y-16.130-16.130
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of HUTCHMED China Ltd is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of HUTCHMED China Ltd:

  • The EOD is 3.356. Based on the equity, the company is fair priced.
  • The MRQ is 3.199. Based on the equity, the company is fair priced.
  • The TTM is 3.199. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.356MRQ3.199+0.157
MRQ3.199TTM3.1990.000
TTM3.199YOY4.326-1.128
TTM3.1995Y3.538-0.339
5Y3.53810Y1.769+1.769
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,274,196
Total Liabilities502,343
Total Stockholder Equity759,929
 As reported
Total Liabilities 502,343
Total Stockholder Equity+ 759,929
Total Assets = 1,274,196

Assets

Total Assets1,274,196
Total Current Assets1,066,555
Long-term Assets207,641
Total Current Assets
Cash And Cash Equivalents 153,958
Short-term Investments 682,152
Net Receivables 155,537
Inventory 50,400
Total Current Assets  (as reported)1,066,555
Total Current Assets  (calculated)1,042,047
+/- 24,508
Long-term Assets
Property Plant Equipment 96,995
Long-term Assets Other 15,433
Long-term Assets  (as reported)207,641
Long-term Assets  (calculated)112,428
+/- 95,213

Liabilities & Shareholders' Equity

Total Current Liabilities376,562
Long-term Liabilities125,781
Total Stockholder Equity759,929
Total Current Liabilities
Short Long Term Debt 23,372
Accounts payable 42,521
Other Current Liabilities 5,663
Total Current Liabilities  (as reported)376,562
Total Current Liabilities  (calculated)71,556
+/- 305,006
Long-term Liabilities
Long term Debt 59,434
Capital Lease Obligations Min Short Term Debt7,014
Long-term Liabilities Other 10,836
Long-term Liabilities  (as reported)125,781
Long-term Liabilities  (calculated)77,284
+/- 48,497
Total Stockholder Equity
Total Stockholder Equity (as reported)759,929
Total Stockholder Equity (calculated)0
+/- 759,929
Other
Capital Stock87,160
Common Stock Shares Outstanding 854,884
Net Invested Capital 842,735
Net Working Capital 689,993
Property Plant and Equipment Gross 156,312



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-31
> Total Assets 
62,882
133,045
127,563
117,957
127,755
159,925
194,774
209,465
185,667
218,938
229,754
342,437
597,932
532,118
465,122
724,118
1,372,661
1,029,445
1,279,773
1,274,196
1,274,1961,279,7731,029,4451,372,661724,118465,122532,118597,932342,437229,754218,938185,667209,465194,774159,925127,755117,957127,563133,04562,882
   > Total Current Assets 
29,975
98,797
88,443
77,925
83,859
107,756
140,635
150,610
67,034
94,130
89,667
167,380
432,195
370,541
317,022
530,740
1,212,076
839,888
1,096,839
1,066,555
1,066,5551,096,839839,8881,212,076530,740317,022370,541432,195167,38089,66794,13067,034150,610140,635107,75683,85977,92588,44398,79729,975
       Cash And Cash Equivalents 
5,617
10,070
53,345
38,206
41,752
45,310
53,763
62,009
46,863
51,125
31,941
79,431
85,265
86,036
121,157
235,630
377,542
313,278
283,589
153,958
153,958283,589313,278377,542235,630121,15786,03685,26579,43131,94151,12546,86362,00953,76345,31041,75238,20653,34510,0705,617
       Short-term Investments 
0
60,544
0
0
0
4,215
0
0
0
12,525
800
24,270
273,031
214,915
96,011
199,546
634,158
317,718
602,747
682,152
682,152602,747317,718634,158199,54696,011214,915273,03124,27080012,5250004,21500060,5440
       Net Receivables 
0
0
2,204
2,572
4,577
5,078
0
63,283
18,751
36,037
47,921
48,928
57,246
42,958
43,254
47,870
83,580
97,988
116,894
155,537
155,537116,89497,98883,58047,87043,25442,95857,24648,92847,92136,03718,75163,28305,0784,5772,5722,20400
       Inventory 
8,677
9,491
11,723
14,715
17,475
26,631
28,720
25,318
1,420
4,405
9,555
12,822
11,789
12,309
16,208
19,766
35,755
56,690
50,258
50,400
50,40050,25856,69035,75519,76616,20812,30911,78912,8229,5554,4051,42025,31828,72026,63117,47514,71511,7239,4918,677
       Other Current Assets 
15,681
18,693
21,171
22,431
20,054
30,738
58,153
3,940
3,962
14,742
250
620
2,015
57,281
37,860
24,067
78,280
152,202
40,672
0
040,672152,20278,28024,06737,86057,2812,01562025014,7423,9623,94058,15330,73820,05422,43121,17118,69315,681
   > Long-term Assets 
32,908
34,248
39,120
40,032
43,896
52,169
54,139
58,855
118,633
124,808
140,087
175,057
165,737
161,577
148,100
193,378
160,585
189,557
182,934
207,641
207,641182,934189,557160,585193,378148,100161,577165,737175,057140,087124,808118,63358,85554,13952,16943,89640,03239,12034,24832,908
       Property Plant Equipment 
22,011
27,103
31,511
32,028
30,652
29,933
29,452
33,288
6,536
8,918
9,850
11,174
15,481
17,790
27,481
45,307
66,323
84,669
104,392
96,995
96,995104,39284,66966,32345,30727,48117,79015,48111,1749,8508,9186,53633,28829,45229,93330,65232,02831,51127,10322,011
       Goodwill 
0
0
0
0
0
0
0
8,311
407
1,953
3,332
3,137
3,308
3,186
3,112
3,307
3,380
0
0
0
0003,3803,3073,1123,1863,3083,1373,3321,9534078,3110000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
144,237
0
0
0
0
0
0
0
0000000144,237000000000000
       Intangible Assets 
6,811
7,017
7,218
7,527
12,484
18,021
23,106
15,585
407
666
571
469
430
347
275
227
163
0
0
0
00016322727534743046957166640715,58523,10618,02112,4847,5277,2187,0176,811
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
1,771
3,542
3,110
19,398
18,153
30,952
31,111
0
0
0031,11130,95218,15319,3983,1103,5421,77100000000000
> Total Liabilities 
90,892
23,063
29,957
33,531
52,454
91,119
117,445
125,817
80,831
99,055
127,477
138,377
112,966
119,863
152,219
205,169
333,147
392,575
536,386
502,343
502,343536,386392,575333,147205,169152,219119,863112,966138,377127,47799,05580,831125,817117,44591,11952,45433,53129,95723,06390,892
   > Total Current Liabilities 
90,892
23,063
29,957
33,243
49,865
67,646
88,476
81,068
78,434
69,185
81,062
95,119
104,600
85,479
113,101
158,397
311,658
353,903
403,027
376,562
376,562403,027353,903311,658158,397113,10185,479104,60095,11981,06269,18578,43481,06888,47667,64649,86533,24329,95723,06390,892
       Short-term Debt 
7,385
7,115
6,563
7,606
8,112
24,500
30,038
11,202
51,508
26,282
23,077
19,957
29,987
432
3,216
2,785
26,905
3,708
35,082
0
035,0823,70826,9052,7853,21643229,98719,95723,07726,28251,50811,20230,03824,5008,1127,6066,5637,1157,385
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
29,987
0
0
0
26,905
0
31,155
23,372
23,37231,155026,90500029,987000000000000
       Accounts payable 
3,938
3,184
5,302
5,290
8,165
10,558
16,452
18,897
11,537
29,143
24,086
35,538
24,365
25,625
23,961
31,612
41,177
71,115
36,327
42,521
42,52136,32771,11541,17731,61223,96125,62524,36535,53824,08629,14311,53718,89716,45210,5588,1655,2905,3023,1843,938
       Other Current Liabilities 
83,507
15,948
23,394
25,637
41,753
43,146
40,913
4,095
12,269
13,196
32,728
37,763
47,671
59,854
445
374
17,191
282,788
331,618
5,663
5,663331,618282,78817,19137444559,85447,67137,76332,72813,19612,2694,09540,91343,14641,75325,63723,39415,94883,507
   > Long-term Liabilities 
0
0
0
289
2,589
23,473
28,968
44,749
2,397
29,870
46,415
43,258
8,366
34,384
39,118
46,772
21,489
38,672
133,359
125,781
125,781133,35938,67221,48946,77239,11834,3848,36643,25846,41529,8702,39744,74928,96823,4732,589289000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
26,830
0
26,739
29,867
32,925
7,161
0
0
0
0007,16132,92529,86726,739026,83000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
7,787
7,066
8,672
13,268
14,328
15,372
0
0
0015,37214,32813,2688,6727,0667,787000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
180
1,171
0
0
0
0
00001,17118000000000000000
> Total Stockholder Equity
-33,671
102,952
90,296
75,143
65,903
59,553
64,784
70,578
88,870
94,889
83,356
184,270
461,733
388,996
288,012
484,116
986,893
610,367
730,541
759,929
759,929730,541610,367986,893484,116288,012388,996461,733184,27083,35694,88988,87070,57864,78459,55365,90375,14390,296102,952-33,671
   Common Stock
0
51,213
51,228
51,229
51,278
51,743
51,744
52,048
52,051
53,076
56,533
60,706
66,447
66,658
66,691
72,772
86,453
86,478
87,126
0
087,12686,47886,45372,77266,69166,65866,44760,70656,53353,07652,05152,04851,74451,74351,27851,22951,22851,2130
   Retained Earnings -833,172-870,869-971,481-610,328-415,591-289,734-183,004-107,104-80,357-92,040-69,185-74,447-89,989-93,807-94,726-86,879-78,014-60,478-43,780-34,145
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
208,196
496,960
505,585
514,904
822,458
1,505,196
0
0
0
0001,505,196822,458514,904505,585496,960208,19600000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
473
95,518
99,546
101,927
101,504
102,536
106,847
108,519
94,171
101,128
113,848
208,196
496,960
505,342
511,055
822,458
1,505,196
1,495,370
1,514,284
0
01,514,2841,495,3701,505,196822,458511,055505,342496,960208,196113,848101,12894,171108,519106,847102,536101,504101,92799,54695,518473



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue630,201
Cost of Revenue-348,884
Gross Profit281,317281,317
 
Operating Income (+$)
Gross Profit281,317
Operating Expense-670,811
Operating Income-40,610-389,494
 
Operating Expense (+$)
Research Development212,109
Selling General Administrative112,913
Selling And Marketing Expenses-
Operating Expense670,811325,022
 
Net Interest Income (+$)
Interest Income40,080
Interest Expense-2,872
Other Finance Cost-0
Net Interest Income37,208
 
Pretax Income (+$)
Operating Income-40,610
Net Interest Income37,208
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-1,107-40,610
EBIT - interestExpense = -2,872
37,729
40,601
Interest Expense2,872
Earnings Before Interest and Taxes (EBIT)-1,765
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-1,107
Tax Provision-7,192
Net Income From Continuing Ops38,170-8,299
Net Income37,729
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--37,208
 

Technical Analysis of HUTCHMED China Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of HUTCHMED China Ltd. The general trend of HUTCHMED China Ltd is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine HUTCHMED China Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. HUTCHMED China Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of HUTCHMED China Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 26.45 < 26.60 < 26.80.

The bearish price targets are: 18.36 > 17.44.

Know someone who trades $0013? Share this with them.👇

HUTCHMED China Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of HUTCHMED China Ltd. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

HUTCHMED China Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of HUTCHMED China Ltd. The current macd is 0.03245481.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the HUTCHMED China Ltd price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for HUTCHMED China Ltd. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the HUTCHMED China Ltd price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
HUTCHMED China Ltd Daily Moving Average Convergence/Divergence (MACD) ChartHUTCHMED China Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of HUTCHMED China Ltd. The current adx is 13.70.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell HUTCHMED China Ltd shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
HUTCHMED China Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of HUTCHMED China Ltd. The current sar is 19.43.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
HUTCHMED China Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of HUTCHMED China Ltd. The current rsi is 51.05. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
HUTCHMED China Ltd Daily Relative Strength Index (RSI) ChartHUTCHMED China Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of HUTCHMED China Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the HUTCHMED China Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
HUTCHMED China Ltd Daily Stochastic Oscillator ChartHUTCHMED China Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of HUTCHMED China Ltd. The current cci is 27.83.

HUTCHMED China Ltd Daily Commodity Channel Index (CCI) ChartHUTCHMED China Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of HUTCHMED China Ltd. The current cmo is 3.94846925.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
HUTCHMED China Ltd Daily Chande Momentum Oscillator (CMO) ChartHUTCHMED China Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of HUTCHMED China Ltd. The current willr is -29.00552486.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that HUTCHMED China Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
HUTCHMED China Ltd Daily Williams %R ChartHUTCHMED China Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of HUTCHMED China Ltd.

HUTCHMED China Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of HUTCHMED China Ltd. The current atr is 1.66011061.

HUTCHMED China Ltd Daily Average True Range (ATR) ChartHUTCHMED China Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of HUTCHMED China Ltd. The current obv is 42,174,682.

HUTCHMED China Ltd Daily On-Balance Volume (OBV) ChartHUTCHMED China Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of HUTCHMED China Ltd. The current mfi is 72.51.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
HUTCHMED China Ltd Daily Money Flow Index (MFI) ChartHUTCHMED China Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for HUTCHMED China Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-11-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-30RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-31STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-01-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-15SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-03STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-02-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-21ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-02-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-05STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-10SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-03-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-20SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-24WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-04-29STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

HUTCHMED China Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of HUTCHMED China Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.046
Ma 20Greater thanMa 5022.977
Ma 50Greater thanMa 10023.753
Ma 100Greater thanMa 20023.479
OpenGreater thanClose23.550
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of HUTCHMED China Ltd with someone you think should read this too:
  • Are you bullish or bearish on HUTCHMED China Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about HUTCHMED China Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about HUTCHMED China Ltd

I send you an email if I find something interesting about HUTCHMED China Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about HUTCHMED China Ltd.

Receive notifications about HUTCHMED China Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.